Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Quote:
Relief continues to run on the thinnest of infrastructure, outsourcing key functions, with no apparent signs of internal ramp-up efforts, internal talent acquisition, etc.

I don't think they can run so thin with what is shaping up to be a worldwide covid solution. And... they don't seem to be in "holy crap we need to get some people on board fast" mode.~Uncle Gee Gee Relief Therapeutics Holding AG (RLFTF)>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

It is quite common for boutique pharma companies, biotech firms, and university labs to license their intellectual property (a new compound) to large pharmaceutical companies. In such cases, the big pharma companies finance and manage the R&D process and, if successful, market the drugs. In exchange for use of their intellectual property, the outlicensing organizations receive licensing contracts that promise some combination of fixed payments, event-specific milestone payments, and revenue- or profit-based royalties. https://doi.org/10.1111/jacf.12252
Why not acquire?? How much, 50bn?? Does $4 B of company valuation translates to $50/s??>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Quote: Valuation is impossible atm but if I'd guess how much the company was sold for, my "guess" would be 100B+ easy... Its just that though, a guess....

Effective treatment for a global pandemic afflicting millions and disrupting world economies, what is that worth? Oh you say it might help with other respiratory afflictions too, stack that valuation on top of the pandemic treatment value as if even it matters. Until I have some sound rational idea(Not for the foreseeable future), I'm not moving anything. 0.2% Minority Owner, see you at the annual shareholders meeting! ~J-Belford, post 9/18/20